Lv7
3355 积分 2020-11-13 加入
Real-world effectiveness and safety of ofatumumab in relapsing multiple sclerosis: A multicenter cohort study
15天前
已关闭
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing–Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study
18天前
已完结
An aggressive form of MOGAD treated with aHSCT: A case report
18天前
已完结
Rituximab as acute rescue therapy for paediatric MOGAD refractory to standard treatment
18天前
已完结
Single-cell RNA sequencing of cerebrospinal fluid immune cells in relapsing–remitting multiple sclerosis: insights into cellular composition and immune dynamics
23天前
已完结
Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing–remitting multiple sclerosis: a multi-center validation study
23天前
已完结
Single‐cell RNA sequencing reveals diverse B cell phenotypes in patients with anti‐NMDAR encephalitis
24天前
已完结
Antibody-Mediated Encephalitis
24天前
已完结
Reassessing B cell contributions in multiple sclerosis
24天前
已完结
Exploring the wearing-off phenomenon among anti-CD20 therapies in multiple sclerosis
29天前
已关闭
皖公网安备34019202002308
